Cargando…
Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application
Despite recent advances in the management of ovarian cancer, it remains the most lethal gynecologic malignancy. Vascular endothelial growth factor (VEGF) has been shown to play a pivotal role in the progression of ovarian cancer leading to the eventual development of malignant ascites. On this basis...
Autores principales: | Amini, Afshin, Masoumi Moghaddam, Samar, Morris, David L., Pourgholami, Mohammad H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180777/ https://www.ncbi.nlm.nih.gov/pubmed/21961001 http://dx.doi.org/10.1155/2012/540791 |
Ejemplares similares
-
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
por: Masoumi Moghaddam, Samar, et al.
Publicado: (2011) -
Initial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines
por: Moghaddam, Samar Masoumi, et al.
Publicado: (2012) -
Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2015) -
The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2014) -
Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2015)